Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 9003
TargetSerine hydroxymethyltransferase, mitochondrial(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
Affinity DataIC50: 0.170nMAssay Description:Inhibition of human SHMT by compounds in this disclosure is evaluated, for example, in their racemic forms in an in vitro assay. For example, Compoun...More data for this Ligand-Target Pair
TargetSerine hydroxymethyltransferase, mitochondrial(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
Affinity DataIC50: 0.400nMAssay Description:Inhibition of human SHMT by compounds in this disclosure is evaluated, for example, in their racemic forms in an in vitro assay. For example, Compoun...More data for this Ligand-Target Pair
TargetSerine hydroxymethyltransferase, cytosolic(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
TargetSerine hydroxymethyltransferase, mitochondrial(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
Affinity DataIC50: 0.650nMAssay Description:Inhibition of human SHMT by compounds in this disclosure is evaluated, for example, in their racemic forms in an in vitro assay. For example, Compoun...More data for this Ligand-Target Pair
TargetSerine hydroxymethyltransferase, mitochondrial(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
Affinity DataIC50: 0.790nMAssay Description:Inhibition of human SHMT by compounds in this disclosure is evaluated, for example, in their racemic forms in an in vitro assay. For example, Compoun...More data for this Ligand-Target Pair
TargetSerine hydroxymethyltransferase, mitochondrial(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
Affinity DataIC50: 0.800nMAssay Description:Inhibition of human SHMT by compounds in this disclosure is evaluated, for example, in their racemic forms in an in vitro assay. For example, Compoun...More data for this Ligand-Target Pair
TargetSerine hydroxymethyltransferase, mitochondrial(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
Affinity DataIC50: 1nMAssay Description:Inhibition of human SHMT by compounds in this disclosure is evaluated, for example, in their racemic forms in an in vitro assay. For example, Compoun...More data for this Ligand-Target Pair
TargetSerine hydroxymethyltransferase, mitochondrial(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
Affinity DataIC50: 1.40nMAssay Description:Inhibition of human SHMT by compounds in this disclosure is evaluated, for example, in their racemic forms in an in vitro assay. For example, Compoun...More data for this Ligand-Target Pair
TargetSerine hydroxymethyltransferase, cytosolic(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
TargetSerine hydroxymethyltransferase, mitochondrial(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
Affinity DataIC50: 1.70nMAssay Description:Inhibition of human SHMT by compounds in this disclosure is evaluated, for example, in their racemic forms in an in vitro assay. For example, Compoun...More data for this Ligand-Target Pair
TargetSerine hydroxymethyltransferase, mitochondrial(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
Affinity DataIC50: 2nMAssay Description:Inhibition of human SHMT by compounds in this disclosure is evaluated, for example, in their racemic forms in an in vitro assay. For example, Compoun...More data for this Ligand-Target Pair
TargetSerine hydroxymethyltransferase, cytosolic(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
TargetSerine hydroxymethyltransferase, cytosolic(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
TargetSerine hydroxymethyltransferase, mitochondrial(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
Affinity DataIC50: 4nMAssay Description:Inhibition of human SHMT by compounds in this disclosure is evaluated, for example, in their racemic forms in an in vitro assay. For example, Compoun...More data for this Ligand-Target Pair
TargetSerine hydroxymethyltransferase, cytosolic(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
TargetSerine hydroxymethyltransferase, mitochondrial(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
Affinity DataIC50: 7.5nMAssay Description:Inhibition of human SHMT by compounds in this disclosure is evaluated, for example, in their racemic forms in an in vitro assay. For example, Compoun...More data for this Ligand-Target Pair
TargetSerine hydroxymethyltransferase, cytosolic(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
TargetSerine hydroxymethyltransferase, cytosolic(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
TargetSerine hydroxymethyltransferase, mitochondrial(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
Affinity DataIC50: 19nMAssay Description:Inhibition of human SHMT by compounds in this disclosure is evaluated, for example, in their racemic forms in an in vitro assay. For example, Compoun...More data for this Ligand-Target Pair
TargetSerine hydroxymethyltransferase, mitochondrial(Human)
The Trustees of Princeton University
US Patent
The Trustees of Princeton University
US Patent
Affinity DataIC50: 43nMAssay Description:Inhibition of human SHMT by compounds in this disclosure is evaluated, for example, in their racemic forms in an in vitro assay. For example, Compoun...More data for this Ligand-Target Pair
